Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2010
10/14/2010CA2757345A1 Pharmaceutical composition
10/14/2010CA2757237A1 Anti-il-23 immunoglobulins
10/14/2010CA2757104A1 Antibodies against il-17br
10/14/2010CA2756824A1 Aberrant mitochondrial dna, associated fusion transcripts and translation products and hybridization probes therefor
10/14/2010CA2756246A1 Amatoxin-armed target-binding moieties for the treatment of cancer
10/14/2010CA2756245A1 Antibodies against human tweak and uses thereof
10/14/2010CA2750836A1 Anti-siglec-15 antibody
10/13/2010EP2239581A1 Phosphorylation of histone H3 at threonine 11 - a novel epigenetic mark for transcriptional regulation
10/13/2010EP2239576A1 Composition and method for diagnosis or detection of gastric cancer
10/13/2010EP2239575A1 Reagent for detecting hiv-1 antigen and detection method
10/13/2010EP2239573A2 Doxorubicin derivates and conjugates for doxorubicin immunoassay
10/13/2010EP2239340A2 Identification of surface-oriented antigens for tumour diagnosis and treatment
10/13/2010EP2239323A1 Humanized anti-human 9-integrin antibody
10/13/2010EP2239274A1 New methods for diagnosis and treatment of tumours
10/13/2010EP2239273A1 A pharmaceutical composition comprosing an immunoglobulin fc as a carrier
10/13/2010EP2239272A2 Specific protein of the pancreatic beta cells of the Langerhans' islands and applications thereof
10/13/2010EP2239271A1 Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereof
10/13/2010EP2239267A1 Tag peptide and use thereof
10/13/2010EP2238986A2 Sp35 antibodies and uses thereof
10/13/2010EP2238456A1 Cell staining assay and kit
10/13/2010EP2238242A1 Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them
10/13/2010EP2238173A1 Bivalent, bispecific antibodies
10/13/2010EP2238172A1 Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof
10/13/2010EP2238171A1 An anti-cancer cytotoxic monoclonal antibody
10/13/2010EP2238170A1 Antibodies against human cd39 and use thereof for inhibiting t regulatory cells activity
10/13/2010EP2238169A1 Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates
10/13/2010EP2238168A1 Agents targeting cd138 and uses thereof
10/13/2010EP2238167A2 Anti-t. cruzi antibodies and methods of use
10/13/2010EP2238166A2 Use of anti-amyloid beta antibody in ocular diseases
10/13/2010EP2238165A2 Anti-hiv domain antibodies and method of making and using same
10/13/2010EP2238156A1 Methods to stabilize proteins and polypeptides
10/13/2010EP2238155A2 Cynomolgus toll-like receptor 3
10/13/2010EP2237803A2 Treatment and prophylaxis of amyloidosis
10/13/2010EP2237792A1 Anti-c35 antibody combination therapies and methods
10/13/2010EP1656391B1 Modified human igf-1r antibodies
10/13/2010EP1633779B1 Oxidoreductase from pichia capsulata
10/13/2010EP1625393B1 Vaccines conferring protection to infection by Streptococcus pneumonia.
10/13/2010EP1503785B1 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
10/13/2010EP1487967B1 Chimeric pancreas
10/13/2010EP1381631B1 Human anti timp-1 antibodies
10/13/2010CN201605242U 可调式蛋白超滤机 Adjustable protein ultrafiltration machine
10/13/2010CN1953768B Highly concentrated liquid formulations of anti-EGFR antibodies
10/13/2010CN1919869B CYP3A4 polypeptide
10/13/2010CN1864068B Methods for reducing complexity of a sample using small epitope antibodies
10/13/2010CN1726394B Sets of digital antibodies directed against short epitopes, and methods using same
10/13/2010CN1563088B Specific composite IgY for anti influenza and preparation
10/13/2010CN1395581B Recombinant antibodies to human IL-1 beta
10/13/2010CN101861521A High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest
10/13/2010CN101861336A Human GM-CSF antigen binding proteins
10/13/2010CN101861164A Treatment of prion protein related diseases
10/13/2010CN101858911A Method for simultaneously detecting antigen and antibody of infectious microorganism
10/13/2010CN101857866A Method for screening single chain antibodies of Microcystin-LR and verification thereof
10/13/2010CN101857637A Anti-norfloxacin polyclonal antibody and preparation method and application
10/13/2010CN101857636A Anti-interferon-alpha antibodies
10/13/2010CN101857635A Continuous separation method for three proteins in bovine plasma
10/13/2010CN101857634A Activator protein for fibrinolytic system
10/13/2010CN101307303B Kit for detecting clenobuterol hydrochloride residue and method for preparing same
10/13/2010CN101245107B Antihuman transferrin acceptor human source antibody and uses thereof
10/13/2010CN101134772B Method for separating membrane protein of sucking sperm rear head and uses thereof
10/13/2010CN101054413B Tumor correlated albumen, coding gene and application thereof
10/12/2010US7812136 useful for monitoring the (de)activation status if the patient is treated with thrombocyte aggregation inhibitors
10/12/2010US7812135 GITR-binding antibodies
10/12/2010US7812134 Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
10/12/2010US7812133 Anti-OX40L antibodies and methods using same
10/12/2010US7812130 fusion protein comprising an isolated soluble cytokine receptor polypeptide; use in treatment of cell proliferative, inflammatory and immune disorders
10/12/2010US7812125 Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions
10/12/2010US7811791 nucleic acid ; for diagnosis, treatment, amelioration, and/or prevention of diseases, disorders, and conditions associated with IFN-L polypeptides
10/12/2010US7811789 Expression vector comprising nucleotide sequences coding migration stimulation factor for use in identifying modulator for treatment and prevention of cell proliferative disorders; wound healing agents
10/12/2010US7811785 capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, edema, inflammation
10/12/2010US7811772 Using high density lipoprotein expression pattern as evaluative tool in diagnosis of urogenital cell proliferative disorders
10/12/2010US7811770 Method of detecting a subfraction of proBNP
10/12/2010US7811769 Methods for aiding in the diagnosis of Alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
10/12/2010US7811588 Therapeutic agent for treatment and prevention of bacterial infections; immunoassay
10/12/2010US7811581 immunogens; tumor antigens; devoid of immunosuppressive domain; fusion proteins; immunotherapy
10/12/2010US7811580 Chimeric HIV Env proteins comprising CD4 mini-proteins or CD4 mimetics that are capable of inducing neutralizing antibody responses against cryptic Env epitopes
10/12/2010US7811572 preparing a cell-binding agent chemically coupled to a drug; covalently attaching a linker to a cell-binding agent, a purification step, conjugating a drug to the cell-binding agent and a subsequent purification step; high purity and stability
10/12/2010US7811570 ablating a targeted non-malignant B cell, comprising administering to a human subject having an immune disease an unconjugated monoclonal antibody (LL2 antibody) which binds to a marker that is specific for a B cell
10/12/2010US7811569 Recombinant anti-Plasmodium falciparum antibodies
10/12/2010US7811567 Methods of using antibodies against human IL-22
10/12/2010US7811566 Antibody-induced apoptosis
10/12/2010US7811565 Antibodies and related molecules that bind to 161P2F10B proteins
10/12/2010US7811564 antibodies and their use for detecting, imaging, staging, treating and monitoring of prostate cancer, and/or metastasis; prostate specific membrane antigen (PSMA)
10/12/2010US7811563 A beta -derived diffusible ligands (ADDL) specific immunoglobulin for use in prevention and treatment of alzheimer's diseases
10/12/2010CA2497287C Method of humanizing immune system molecules
10/12/2010CA2419205C Anti-tnf antibodies, compositions, methods and uses
10/12/2010CA2367468C Rheumatoid arthritis gene and method for diagnosing rheumatoid arthritis
10/12/2010CA2336114C Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof
10/12/2010CA2308765C The use of an ox-2 protein or nucleic acid in immunomodulation
10/12/2010CA2307065C Modulating robo:ligand interactions
10/12/2010CA2229590C Pharmaceutical composition containing inhibitors of interferon- gamma
10/07/2010WO2010115210A2 Mouse models
10/07/2010WO2010115094A2 Methods for determine atherosclerosis regression, plaque stabilization and cardiovascular risk
10/07/2010WO2010114940A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
10/07/2010WO2010114860A1 Bmp-alk3 antagonists and uses for promoting bone growth
10/07/2010WO2010114859A1 Treatment of insulin-resistant disorders
10/07/2010WO2010114312A2 Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same
10/07/2010WO2010114106A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010114105A1 Monoclonal antibody capable of binding to ad2 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010113988A1 Method for producing anti-gpcr antibody and anti-gpcr antibody
10/07/2010WO2010113627A1 Highly sensitive detection method for highly virulent oral cavity bacteria
1 ... 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 ... 1494